This editorial underscores the benefits of combining exercise, nutrition, and psychosocial support in bladder cancer care to enhance patients’ quality of life and recovery outcomes. Evidence from mul…
A team of 15 determined individuals, including multiple myeloma cancer survivors, care partners, and world-renowned physicians, embark on the Iceland Cycling…
Background Nemvaleukin alfa (nemvaleukin, ALKS 4230) is a novel, engineered cytokine that selectively binds to the intermediate-affinity interleukin-2 receptor, preferentially activating CD8+ T cells and…
Shubham Pant, MD, MBBS, highlights an “exciting time” in the treatment of patients with RAS-mutated pancreatic cancer.
Learn more about Reza Mehrazin, specializing in Urology at the Mount Sinai Health System. Call or book online for an appointment.
The circumstances and positive testing of a raw milk sample in California don’t make sense, say experts. Something is amiss.
PURPOSEThe CLL12 trial reassesses the watch-and-wait consensus for early-stage chronic lymphocytic leukemia (CLL) in the context of targeted therapies.METHODSThe German CLL Study Group conducted a…
Nature – No difference in survival outcomes between use of CDK4/6 inhibitors as first- or second-line treatment in metastatic breast cancer.
Program: Oral and Poster Abstracts Type: Oral Session: 655. Multiple Myeloma: Cellular Therapies: Unleashing Cell Therapies Against Myeloma Hematology Disease Topics & Pathways: Research, Clinical…
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Refining the Evidence: Randomized Trials in Multiple Myeloma Hematology Disease Topics &…
